Search

Your search keyword '"Dansonka-Mieszkowska, Agnieszka"' showing total 354 results

Search Constraints

Start Over You searched for: Author "Dansonka-Mieszkowska, Agnieszka" Remove constraint Author: "Dansonka-Mieszkowska, Agnieszka"
354 results on '"Dansonka-Mieszkowska, Agnieszka"'

Search Results

1. An Analysis of Genetic Polymorphisms in 76 Genes Related to the Development of Ovarian Tumors of Different Aggressiveness.

2. Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility

4. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.

5. No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival

7. Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration

8. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer

9. Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study.

10. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.

11. Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

12. Assessing the genetic architecture of epithelial ovarian cancer histological subtypes

13. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

14. Evidence of a genetic link between endometriosis and ovarian cancer

15. Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium

16. Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk.

17. Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk.

18. Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer.

19. Genome-wide significant risk associations for mucinous ovarian carcinoma (vol 47, pg 888, 2015)

20. Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci

21. Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study.

22. Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk

23. Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC)

24. Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk.

25. Variation in NF-κB Signaling Pathways and Survival in Invasive Epithelial Ovarian Cancer

26. Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.

27. Large-Scale Evaluation of Common Variation in Regulatory T Cell–Related Genes and Ovarian Cancer Outcome

28. Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10.

29. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.

30. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.

31. Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31

32. Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study

33. Data from Large-Scale Evaluation of Common Variation in Regulatory T Cell–Related Genes and Ovarian Cancer Outcome

34. Supplementary Methods, Figures S1 - S3 from Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

35. Supplementary Tables S1 - S10 from Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

36. Supplementary Acknowledgments from Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

37. Data from Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

38. Supplementary Grant Support from Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

39. Supplementary Tables 1 - 4 from Large-Scale Evaluation of Common Variation in Regulatory T Cell–Related Genes and Ovarian Cancer Outcome

40. Data from Variation in NF-κB Signaling Pathways and Survival in Invasive Epithelial Ovarian Cancer

41. Data from Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk

42. Supplementary Tables S1-6, Figures S1-2 from Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk

43. Supplementary Figures 1-5, Tables 1-8 from Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium

44. Supplementary Tables 1 through 3 from Variation in NF-κB Signaling Pathways and Survival in Invasive Epithelial Ovarian Cancer

45. Data from Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium

46. Data from Risk of Ovarian Cancer and the NF-κB Pathway: Genetic Association with IL1A and TNFSF10

47. Supplementary Tables 1 - 5 from Risk of Ovarian Cancer and the NF-κB Pathway: Genetic Association with IL1A and TNFSF10

48. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

50. PROM1, CXCL8, RUNX1, NAV1 and TP73 genes as independent markers predictive of prognosis or response to treatment in two cohorts of high-grade serous ovarian cancer patients

Catalog

Books, media, physical & digital resources